BNXTFBIONXT SOLUTIONS INC.

About BIONXT SOLUTIONS INC. (BNXTF)

BIONXT SOLUTIONS INC. (BNXTF) is a Drug Manufacturers - Specialty & Generic company headquartered in Vancouver, BC, Canada whose shares trade over-the-counter on the Pink tier.

BioNxt Solutions Inc. is a bioscience accelerator focused on next-generation drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical production and evaluation, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets.

Products and services

BioNxt brings together cutting-edge companies and top researchers from around the world to innovate, accelerate and commercialize disruptive technology, from drug delivery formulations to diagnostics.

BNXTF key facts

Ticker symbol

BNXTF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Vancouver, BC, Canada

Country of incorporation

CA

Year of incorporation

2017

Employees

1

Estimated market cap

$41.09M (as of Apr 11, 2025)

Shares outstanding

115,831,754

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Interim Financial Report (Mar 31, 2024)

BIONXT SOLUTIONS INC. leadership

• Hugh Rogers — CEO
• Patrick Joseph Meagher — CFO
• Victoria Bantz — Consultant
• Carrie Lee-Anne Cesarone — Other

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with B